Label Vision Systems (LVS) will be fully integrated into Microscan and the LVS name will become a brand within Microscan’s barcode label verification portfolio.
Microscan Systems, a company specializing in industrial barcode reading and machine vision technology, announced that it has acquired the trade and assets of Label Vision Systems (LVS). LVS will be fully integrated into Microscan and the LVS name will become a brand within Microscan’s barcode label verification portfolio.
LVS is a provider of label inspection, print inspection, and barcode verification products, solutions, and services for the life sciences and other industries. The company’s offerings allow companies to inspect barcodes either off-line or in-line to achieve 100% compliance to unique device identification (UDI) legislation and GS1 standards, as well as to improve product traceability throughout the manufacturing supply chain.
Scott Summerville, president of Microscan, commented in a press statement that the acquisition is a strategic move for Microscan. “There are many advantages to acquiring the trade and assets of LVS. The leadership team at Microscan has a strong interest in developing and investing in LVS’s technology and products to support the market, which is expanding due to regulatory trends and corporate quality initiatives. We will have the opportunity to accelerate the expansion of LVS products and solutions into key international markets, and to leverage the substantial synergies between LVS and Microscan sales, technology, and operations.”
Source: Microscan
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Drug Solutions Podcast: Emerging Methods of Vaccine Administration and Distribution
June 20th 2023Michael Schrader, CEO and co-founder of Vaxess, discusses the latest on vaccine administration and different ways the pharmaceutical industry can distribute these products with Pharmaceutical Technology editor Jill Murphy.